Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Schulz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Therapeutics|June 4, 2011
A better mousetrapRichard M Schulz
American Journal of Public Health|September 30, 2006
US suicide rates by age group, 1970-2002: an examination of recent trendsRobert E McKeown, Steven P Cuffe, Richard M Schulz
Research in Social & Administrative Pharmacy : RSAP|September 13, 2015
Implementation of the American Diabetes Association's Standards of Medical Care post-Medicare Part D: The case of statin utilization in the elderly with diabetesZ Kevin Lu, Minghui Li, Whitney D Maxwell, et al.
The American Journal of Geriatric Pharmacotherapy|April 5, 2011
Impact of a medication management system on nursing home admission rate in a community-dwelling nursing home-eligible Medicaid populationRichard M Schulz, Candace Porter, Marcia Lane, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 6, 2012
Prophylactic ketoconazole shampoo for tinea capitis in a high-risk pediatric populationP Brandon Bookstaver, Holly J Watson, Shauna D Winters, et al.
Pediatric Pulmonology|October 5, 2016
Clinical outcomes of levalbuterol versus racemic albuterol in pediatric patients with asthma: Propensity score matching approach in a medicaid populationJing Yuan, Zhiqiang Kevin Lu, Yanjun Zhang, et al.
Clinical Pharmacology : Advances and Applications|February 1, 2012
Differences in hospital glycemic control and insulin requirements in patients recovering from critical illness and those without prior critical illnessApril D Miller, Leslie M Phillips, Richard M Schulz, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 24, 2008
Cost-benefit analysis of a regional poison centerJoseph Charles Blizzard, Jill E Michels, William H Richardson, et al.
Epilepsy & Behavior : E&B|June 26, 2007
Conversions between monotherapies in epilepsy: expert consensusErik K St Louis, Barry E Gidal, Thomas R Henry, et al.
The Lancet. Oncology|December 3, 2014
Regulatory and clinical considerations for biosimilar oncology drugsCharles L Bennett, Brian Chen, Terhi Hermanson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Therapeutics|June 4, 2011
A better mousetrapRichard M Schulz
American Journal of Public Health|September 30, 2006
US suicide rates by age group, 1970-2002: an examination of recent trendsRobert E McKeown, Steven P Cuffe, Richard M Schulz
Research in Social & Administrative Pharmacy : RSAP|September 13, 2015
Implementation of the American Diabetes Association's Standards of Medical Care post-Medicare Part D: The case of statin utilization in the elderly with diabetesZ Kevin Lu, Minghui Li, Whitney D Maxwell, et al.
The American Journal of Geriatric Pharmacotherapy|April 5, 2011
Impact of a medication management system on nursing home admission rate in a community-dwelling nursing home-eligible Medicaid populationRichard M Schulz, Candace Porter, Marcia Lane, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|April 6, 2012
Prophylactic ketoconazole shampoo for tinea capitis in a high-risk pediatric populationP Brandon Bookstaver, Holly J Watson, Shauna D Winters, et al.
Pediatric Pulmonology|October 5, 2016
Clinical outcomes of levalbuterol versus racemic albuterol in pediatric patients with asthma: Propensity score matching approach in a medicaid populationJing Yuan, Zhiqiang Kevin Lu, Yanjun Zhang, et al.
Clinical Pharmacology : Advances and Applications|February 1, 2012
Differences in hospital glycemic control and insulin requirements in patients recovering from critical illness and those without prior critical illnessApril D Miller, Leslie M Phillips, Richard M Schulz, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 24, 2008
Cost-benefit analysis of a regional poison centerJoseph Charles Blizzard, Jill E Michels, William H Richardson, et al.
Epilepsy & Behavior : E&B|June 26, 2007
Conversions between monotherapies in epilepsy: expert consensusErik K St Louis, Barry E Gidal, Thomas R Henry, et al.
The Lancet. Oncology|December 3, 2014
Regulatory and clinical considerations for biosimilar oncology drugsCharles L Bennett, Brian Chen, Terhi Hermanson, et al.
Pageof 1